In a double-blind study of patients suffering from pain after surgery, fenoprofen 200 mg and paracetamol 500 mg was compared with each drug given separately and with a placebo. There was a significant difference between the combination and the placebo, whereas, separately, the drugs were only marginally better than the placebo in relieving pain. There was a significant linear trend indicating a better clinical result as the number of active components in the regimen was increased.
Fenoprofen (DL-2-(3-phenoxyphenyl)propionic acid) is a non-steroid chemical which has analgesic, antiinflammatory and antipyretic properties in animals (Nickander, Kraay and Marshall, 1971) . The propionic acid derivatives are claimed to have an analgesic potency comparable to that of aspirin and they are regarded now as the first choice in the treatment of rheumatoid arthritis (Huskisson et al., 1976) . Two recent investigations have shown that the analgesic activity of fenoprofen is equal to that of naproxen and that both are superior to ibuprofen and ketoprofen (Reynolds and Whorwell, 1974; Huskisson et al., 1976) . The addition of propoxyphene to fenoprofen has been shown to enhance its analgesic effect (Sunshine and Laska, 1971) .
We have investigated the analgesic effect of combining a single dose of fenoprofen with a single dose of paracetamol, compared with those of the single drugs and with a placebo, in a single-dose doubleblind, between patient comparison in patients suffering from pain after operation. This method has been sufficiently sensitive to evaluate mild analgesics given orally (Davie and Masson, 1970) .
METHODS
We studied 240 consecutive patients who were undergoing surgery which did not interfere with the oral administration of drugs after operation. In four treatment groups of 60 there were 176 females and 64 males in the age range 18-75 yr. All patients had undergone one of five categories of surgical operation: lower abdominal, gynaecological, limb, scrotal and "other". The test drugs were given as soon as oral administration was possible. To maintain double-blind conditions, the drugs were formulated as capsules or tablets, and the medication for each patient was presented in identical individual packs. Allocation of patients to treatment groups was: Group A-1 capsule placebo to match fenoprofen and 1 tablet placebo to match paracetamol. Group B-1 capsule placebo to match fenoprofen and 1 tablet paracetamol 500 mg. Group C-1 capsule fenoprofen 200mg+l tablet placebo to match paracetamol. Group D-1 capsule fenoprofen 200mg+l tablet paracetamol 500 mg. The patients gave their consent to the study. Each patient received one trial dose of medication after operation. No specific selection of patients was made. Pregnant women, those with known renal or hepatic impairment and those who had had surgery of the gastrointestinal tract, and patients who had received analgesic or tranquillizing drugs in the preceding 5 h were excluded.
On admission to the study, the degree of pain intensity was assessed as mild, moderate or severe by observation and by the patients' comments (Parkhouse and Holmes, 1963) . The treatment was given and 2 h later the degree of analgesia was assessed, with reference to the previous pain, by the same investigator. Analgesia was classified no relief, partial relief, considerable relief (if the patient was pain-free while lying still) and complete relief (if the patient was pain-free on moving). All observations were made by the authors.
RESULTS
There was no difference between the groups in respect of age or sex, and the distribution of patients within treatment groups was reasonably uniform for
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Downloaded from https://academic.oup.com/bja/article-abstract/50/9/931/384894 by guest on 13 March 2019 each type of operation and was not statistically different. The patients were distributed equally within the four treatment groups according to their initial degree of pain (table I) .
Pain relief. Evaluation of the maximal therapeutic efficacy of each drug group (assuming peak blood concentrations at about 2 h) is based upon 184 patients for whom the assessment of pain relief was completed at 2 h (56 patients were excluded from analysis, see below).
In the placebo group the high proportion of patients who had partial pain relief at 2 h (20/40) may have resulted from a simple placebo response or a spontaneous decrease in their surgical pain. Therefore only the categories considerable and complete pain relief were regarded as significant, and these are grouped as "adequate pain relief". Partial and no relief are grouped as "inadequate pain relief". There were only a small number of patients with severe initial pain and these were combined with the moderate pain group so that only two categories of initial pain, mild and moderate and severe, were used in the analysis.
Pain relief at 2 h for each category of operation and initial pain are in table II. Statistical analysis was made after combining the categories as described.
The results for all categories of initial pain are in table III. These were analysed using the Brandt and Snedecor approach for a 2 x n contingency table and showed a significant difference between treatment groups (overall x 2 = 8.48, d.f. = 3; P<0.05). Analysis of the components of x 2 between paracetamol-containing treatments (two groups: paracetamol alone and in combination with fenoprofen) and nonparacetamol containing groups (placebo and fenoprofen alone) indicated that, although the paracetamol treatments were not significantly different from nonparacetamol groups, within the paracetamol subset itself the addition of fenoprofen to paracetamol resulted in a significant improvement in pain relief (X 2 = 4.41, d.f. = l;P<0.05).
The greatest proportion of patients with adequate pain relief had received the double-active component. To compare non-active (placebo), single-active and double-active components the two single-active groups (paracetamol and fenoprofen alone) were combined to give a 3 x 2 contingency table (table IV) . The linear trend from non-active (30%), to single-active (41%), to double-active component (60%) was statistically significant (for linear regression, P< 0.01). The results were analysed further according to the degree of initial pain. This showed similar trends in pain relief and, for both categories of initial pain, the proportion of patients achieving adequate pain relief was greatest in the double-active component treatment group (fenoprofen/paracetamol).
Clinical assessment. Clinical assessment of pain relief was based on 232 patients (table V) . The results could not be assessed in eight patients.
Those with adequate pain relief were regarded as "successes". Those with inadequate pain relief are grouped, with patients who had required further analgesia (parenteral) before the 2-h assessment, as "failures". For all types of operation and categories of initial pain, there was a significant difference between the fenoprofen/paracetamol combination and placebo (P< 0.005, Yates x 2 test, modified significance level P = 0.008 (Brunden, 1972) ). Neither fenoprofen nor paracetamol alone were significantly better than the placebo on the basis of a modified significance level (P<0.05 and P<0.25 respectively). Combining the single-active treatment groups, the linear trend from non-active to single-active to double-active component treatment group is very significant (P<0.01), indicating better results as the number of active components in the treatment was increased.
Side-effects. No drug-related side-effects were observed in this study in any of the treatment groups.
DISCUSSION
Fenoprofen is a potent inhibitor of prostaglandin synthesis (Ho and Esterman, 1974) and, as with aspirin and the other non-narcotic analgesics (Guzman and Lim, 1968) , its analgesic activity is mediated by peripheral block of impulse generation. Peak blood concentrations occur about 2 h after oral administration and fenoprofen has a mean half-life of 2.5 h (Rubin et al., 1974) . Paracetamol also possesses the same actions (Guzman and Lim, 1968) , its peak blood concentration occurs 1-2 h after oral administration, and its half-life is between 1 and 3 h (Gwilt et al., 1963; Heading et al., 1973; Prescott and Wright, 1973) .
The similarity in pharmacokinetic profile between the two drugs suggested that a combination of the two is a logical and reasonable step to achieve the same degree of analgesia whilst reducing the sideeffects of each.
Subjective assessment of pain relief was made 2 h after oral administration when the maximal pharmacological effect may be expected. Of the eight patients whose results could not be evaluated, four had anaesthetic-induced vomiting, two had discharged themselves from hospital and two could not be assessed for reasons unrelated to drug therapy. The 232 patients in this clinical assessment included 48 patients who required further analgesic drugs parenterally before the oral medication could have achieved its peak effect. Assessment of pain relief at 2 h was based on 184 patients.
For all categories of initial pain in the placebo group, 30% of patients assessed at 2 h had adequate pain relief; this figure is close to the accepted value for the response to a placebo. As may be expected, the response was less in those patients with moderate and severe pain compared with those with mild pain.
When assessed clinically, treatment was least successful in the lower abdominal group because the initial pain was generally more severe after these operations and approximately 30% of patients with moderate and severe pain required additional analgesic drugs.
Fenoprofen 300 mg has been shown to be superior to a placebo (SantilU and Venerando, 1975) , but in this study fenoprofen 200 mg or paracetamol 500 mg were only marginally better in relieving pain 2h after oral administration. The combination of fenoprofen 200 mg and paracetamol 500 mg resulted in a statistically significant increase in the number of patients with adequate pain relief at 2 h in comparison with the placebo.
The linear trend, from placebo, to single-active component to double-active component treatment groups, in the number of patients achieving adequate analgesia is highly significant. This was present for all categories of operation, but was less marked after lower abdominal surgery where initial pain was greatest. 
SUMARIO
En un estudio de doble anonimato realizado con pacientes que sufrian dolor despuis de cirugia, se comparo fenoprofen 200 mg y paracetamol 500 mg con su administraci6n separada y con un placebo. Se produjo una diferencia significativa entre la combinaci6n y el placebo, mientras que, separadamente, las drogas resultaron solo marginalmente superiores al placebo en al alivio de dolor. Se produjo una tendencia lineal significativa que indic6 un mejor resultado clinico a medida que se aumentaba la cantidad de componentes activos en el regimen.
